These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25938755)

  • 21. [Characterization of genotypes for Burkholderia cepacia complex strains isolated from patients in hospitals of Russian Federation].
    Voronina AL; Chernukha MY; Shaginyan IA; Kunda MS; Avetisyan LR; Orlova AA; Lunin VG; Avakyan LV; Kapranov NI; Amelina EL; Chuchalin AG; Gintsburg A L
    Mol Gen Mikrobiol Virusol; 2013; (2):22-30. PubMed ID: 24003509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand.
    Pope CE; Short P; Carter PE
    J Cyst Fibros; 2010 Dec; 9(6):442-6. PubMed ID: 20833115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
    Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC
    Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species distribution and antimicrobial susceptibility of Burkholderia cepacia complex isolates in clinical infections: Experience from a tertiary care hospital, Southern India.
    Kumaresan M; Manoharan M; Sugumar M; Sistla S
    Indian J Med Microbiol; 2024; 49():100613. PubMed ID: 38750965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
    Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
    Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD
    Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis.
    Brisse S; Cordevant C; Vandamme P; Bidet P; Loukil C; Chabanon G; Lange M; Bingen E
    J Clin Microbiol; 2004 Oct; 42(10):4824-7. PubMed ID: 15472352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.
    Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA
    ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.
    Fraser-Pitt D; Mercer D; Lovie E; Robertson J; O'Neil D
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6200-6. PubMed ID: 27503654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.
    Reik R; Spilker T; Lipuma JJ
    J Clin Microbiol; 2005 Jun; 43(6):2926-8. PubMed ID: 15956421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in isolation of Burkholderia contaminans from Spanish patients with cystic fibrosis.
    Medina-Pascual MJ; Valdezate S; Carrasco G; Villalón P; Garrido N; Saéz-Nieto JA
    Clin Microbiol Infect; 2015 Feb; 21(2):150-6. PubMed ID: 25658563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Traczewski MM; Brown SD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
    De Soyza A; Meachery G; Hester KL; Nicholson A; Parry G; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA
    J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging cystic fibrosis pathogens: incidence and antimicrobial resistance.
    Magni A; Giordano A; Mancini C; Pecoraro C; Varesi P; Quattrucci S; Trancassini M
    New Microbiol; 2007 Jan; 30(1):59-62. PubMed ID: 17319602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burkholderia cepacia complex infections: More complex than the bacterium name suggest.
    Sfeir MM
    J Infect; 2018 Sep; 77(3):166-170. PubMed ID: 30012345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center.
    Leitão JH; Sousa SA; Cunha MV; Salgado MJ; Melo-Cristino J; Barreto MC; Sá-Correia I
    Eur J Clin Microbiol Infect Dis; 2008 Nov; 27(11):1101-11. PubMed ID: 18600352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
    Campana S; Taccetti G; Ravenni N; Favari F; Cariani L; Sciacca A; Savoia D; Collura A; Fiscarelli E; De Intinis G; Busetti M; Cipolloni A; d'Aprile A; Provenzano E; Collebrusco I; Frontini P; Stassi G; Trancassini M; Tovagliari D; Lavitola A; Doherty CJ; Coenye T; Govan JR; Vandamme P
    J Clin Microbiol; 2005 Oct; 43(10):5136-42. PubMed ID: 16207975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management and outcomes of Burkholderia cepacia complex bacteremia in patients without cystic fibrosis: a retrospective observational study.
    Lee YM; Park KH; Moon C; Kim DY; Lee MS; Kim T; Choo EJ; Chong YP; Kim SH; Kim YS; Woo JH; Chang MS
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2057-2064. PubMed ID: 32583228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.